Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126307011 | 12630701 | 1 | I | 201604 | 20160727 | 20160808 | 20160808 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201607012689 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160805 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126307011 | 12630701 | 1 | PS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | UNK, UNKNOWN | U | U | 20563 | ||||||||
| 126307011 | 12630701 | 2 | SS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | UNK, UNKNOWN | U | U | 0 | ||||||||
| 126307011 | 12630701 | 3 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Unknown | UNK, QD | 0 | QD | |||||||||
| 126307011 | 12630701 | 4 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Unknown | UNK, QD | 0 | TID | |||||||||
| 126307011 | 12630701 | 5 | C | ASPEGIC | ASPIRIN DL-LYSINE | 1 | UNK | U | 0 | ||||||||||
| 126307011 | 12630701 | 6 | C | LEVONOX | ENOXAPARIN | 1 | 0.4 ML, QD | U | 0 | .4 | ML | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126307011 | 12630701 | 1 | Product used for unknown indication |
| 126307011 | 12630701 | 2 | Product used for unknown indication |
| 126307011 | 12630701 | 3 | Cutaneous lupus erythematosus |
| 126307011 | 12630701 | 5 | Anticoagulant therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126307011 | 12630701 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126307011 | 12630701 | Diabetes mellitus inadequate control | |
| 126307011 | 12630701 | Exposure during pregnancy | |
| 126307011 | 12630701 | Glycosylated haemoglobin increased | |
| 126307011 | 12630701 | Haematuria | |
| 126307011 | 12630701 | Hypertension | |
| 126307011 | 12630701 | Proteinuria | |
| 126307011 | 12630701 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126307011 | 12630701 | 3 | 2004 | 0 | ||
| 126307011 | 12630701 | 4 | 201606 | 0 | ||
| 126307011 | 12630701 | 5 | 201606 | 0 | ||
| 126307011 | 12630701 | 6 | 201606 | 0 |